Regulation of Cytochrome P450 Biosynthesis

细胞色素 P450 生物合成的调控

• 批准号: 7423937
• 负责人: Byron W Kemper
• 金额: $ 27.64万
• 依托单位: UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
• 依托单位国家: 美国
• 财政年份: 1996
• 资助国家: 美国
• 起止时间: 1996-02-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7423937
• 关键词: Affinity; Agonist; Anabolism; Androstanes; Animals; Binding; Binding Sites; Biological Assay; Cell Nucleus; Cells; Chimera organism; Chimeric Proteins; Chromatin; Chromatin Structure; Complex; Cultured Cells; Cytochrome P450; Cytoplasm; DNA; Drug Interactions; Enhancers; Equilibrium; Gene Activation; Gene Expression; Genes; Genetic Transcription; Goals; Hepatocyte; Hydroxyl Radical; In Vitro; Lead; Ligands; Liver; MYBBP1A gene; Mass Spectrum Analysis; Mediating; Modeling; Modification; Molecular; Mus; Mutagenesis; Nature; Nuclear; Nuclear Export; Nuclear Import; Nuclear Localization Signal; Nuclear Receptors; Nuclear Translocation; Numbers; Okadaic Acid; Phenobarbital; Phosphorylation; Process; Protein phosphatase; Proteins; RXR; Receptor Signaling; Recruitment Activity; Regulation; Relative (related person); Reporter; Research Personnel; Signal Pathway; Signal Transduction; Therapeutic; Toxic effect; Transcriptional Activation; Transfection; Transgenic Mice; androstane; chromatin immunoprecipitation; constitutive androstane receptor; human CYP2B6 protein; in vivo; insight; kinase inhibitor; nuclear receptor coactivator 1; nuclease; nucleocytoplasmic transport; phosphatase inhibitor; programs; promoter; receptor; receptor binding; trafficking

DESCRIPTION (provided by applicant): The overall goal of this project is to understand the molecular mechanisms by which phenobarbital (PB) induces cytochrome P450 gene (CYP) expression. P450s catalyze the activation or inactivation of a wide variety of endogenous and exogenous compounds. Clinically, induction of P450s underlies many drug interactions, and the balance between inactivation and activation, which is influenced by induction, determines the ultimate therapeutic or toxic effect of ingested compounds. PB treatment induces the nuclear translocation of the constitutive androstane receptor (CAR). CAR binds to three nuclear receptor (NR) binding sites in a PB responsive enhancer (PBRU) as a heterodimer with RXR and recruits p160 coactivators and other unknown proteins resulting in changes in chromatin structure and gene activation. The specific aims are to identify the regulatory complex recruited by CAR to the PBRU, to determine changes in chromatin structure at the PBRU correlated with activation of the CYP genes, and to determine the import and export signals of CAR necessary for its nucleocytoplasmic shuttling. To facilitate the isolation of CAR and its protein complexes from mouse liver, a transgenic mouse expressing flag-tagged CAR will be constructed. Nuclear CAR protein complexes in PB-treated animals will be enriched by flag immunoaffinity isolation and proteins in the complex will be identified by mass spectrometry. The relative importance of the three p160 coactivators and the three NR binding sites will be determined. Proteins recruited to the PBRU after PB treatment will be identified by chromatin immunoprecipitation assays and chromatin structure will be probed by sensitivity to cleavage by nucleases and hydroxyl radicals. The functional significance of proteins detected at the PBRU or in CAR complexes will be determined by transient transfections in cultured cells and in hepatocytes in vivo. Nuclear import and export signals and receptors for CAR will be identified by examining the distribution of chimera of CAR fragments and fluorescent proteins in hepatocytes transfected in vivo. These studies, emphasizing in vivo approaches, should provide a description of the regulatory complex at the PBRU, which will provide insight into the mechanism of PB induction of CYP genes, and determine transport signals for nucleocytoplasmic shuttling, which is a key process regulated by PB treatment.

描述（由申请人提供）：本项目的总体目标是了解苯巴比妥（PB）诱导细胞色素P450基因（CYP）表达的分子机制。P450催化多种内源性和外源性化合物的活化或失活。在临床上，P450的诱导是许多药物相互作用的基础，受诱导影响的失活和活化之间的平衡决定了摄入化合物的最终治疗或毒性作用。PB处理诱导组成型雄烷受体（CAR）的核转位。CAR与PB应答增强子（PBRU）中的三个核受体（NR）结合位点结合，作为RXR的异二聚体，并招募p160共激活因子和其他未知蛋白，导致染色质结构和基因激活的变化。具体的目的是确定由CAR募集到PBRU的调节复合物，以确定PBRU处的染色质结构的变化与转录因子基因的激活相关，并确定CAR的核质穿梭所需的输入和输出信号。为了促进CAR及其蛋白质复合物从小鼠肝脏中的分离，将构建表达标记的CAR的转基因小鼠。PB处理的动物中的核CAR蛋白复合物将通过标记免疫亲和分离富集，并且复合物中的蛋白质将通过质谱法鉴定。将确定三个p160共激活因子和三个NR结合位点的相对重要性。PB处理后招募至PBRU的蛋白质将通过染色质免疫沉淀试验进行鉴定，染色质结构将通过对核酸酶和羟基自由基切割的敏感性进行探测。在PBRU或CAR复合物中检测到的蛋白质的功能意义将通过体内培养细胞和肝细胞中的瞬时转染来确定。将通过检查CAR片段和荧光蛋白的嵌合体在体内转染的肝细胞中的分布来鉴定CAR的核输入和输出信号和受体。这些研究，强调在体内的方法，应该提供一个描述的调节复合物在PBRU，这将提供深入了解PB诱导的ESTA基因的机制，并确定运输信号的核质穿梭，这是一个关键的过程，由PB治疗调节。